These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 38087359)

  • 1. Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective.
    Nayab DE; Din FU; Ali H; Kausar WA; Urooj S; Zafar M; Khan I; Shabbir K; Khan GM
    J Nanobiotechnology; 2023 Dec; 21(1):477. PubMed ID: 38087359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders.
    Fatima J; Siddique YH
    CNS Neurol Disord Drug Targets; 2024; 23(10):1217-1233. PubMed ID: 38288843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K
    Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
    Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders.
    Nguyen KT; Pham MN; Vo TV; Duan W; Tran PH; Tran TT
    Curr Drug Metab; 2017; 18(9):786-797. PubMed ID: 28124594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders.
    Guo ZH; Khattak S; Rauf MA; Ansari MA; Alomary MN; Razak S; Yang CY; Wu DD; Ji XY
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases.
    Masoudi Asil S; Ahlawat J; Guillama Barroso G; Narayan M
    Biomater Sci; 2020 Aug; 8(15):4109-4128. PubMed ID: 32638706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology-based drug delivery for central nervous system disorders.
    Nguyen TT; Dung Nguyen TT; Vo TK; Tran NM; Nguyen MK; Van Vo T; Van Vo G
    Biomed Pharmacother; 2021 Nov; 143():112117. PubMed ID: 34479020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics.
    Lamptey RNL; Chaulagain B; Trivedi R; Gothwal A; Layek B; Singh J
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
    Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
    Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles-Focus on Alzheimer's and Parkinson's disease.
    Hernando S; Santos-Vizcaíno E; Igartua M; Hernandez RM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1898. PubMed ID: 37157144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Functional Roles of Curcumin on Astrocytes in Neurodegenerative Diseases.
    Mohammadi A; Hosseinzadeh Colagar A; Khorshidian A; Amini SM
    Neuroimmunomodulation; 2022; 29(1):4-14. PubMed ID: 34496365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria-targeted nanoparticles in treatment of neurodegenerative diseases.
    Zhang Y; Yang H; Wei D; Zhang X; Wang J; Wu X; Chang J
    Exploration (Beijing); 2021 Dec; 1(3):20210115. PubMed ID: 37323688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatment of neurodegenerative disorders employing nanotechnology.
    Modi G; Pillay V; Choonara YE
    Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment.
    Naz S; Beach J; Heckert B; Tummala T; Pashchenko O; Banerjee T; Santra S
    Nanomedicine (Lond); 2017 Mar; 12(5):545-553. PubMed ID: 28181459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders.
    Mazibuko Z; Choonara YE; Kumar P; Du Toit LC; Modi G; Naidoo D; Pillay V
    J Pharm Sci; 2015 Apr; 104(4):1213-29. PubMed ID: 25559087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
    Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
    Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance.
    Rhaman MM; Islam MR; Akash S; Mim M; Noor Alam M; Nepovimova E; Valis M; Kuca K; Sharma R
    Front Cell Dev Biol; 2022; 10():989471. PubMed ID: 36120565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.